Commentary on herpes zoster guidelines of the German dermatological society

Journal of Clinical Virology

Volumn 26, Issue 3, 2003, Pages 291-293

  Breuer, Judy ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; AMITRIPTYLINE; ANTIVIRUS AGENT; CARBAMAZEPINE; CIDOFOVIR; FAMCICLOVIR; FLUOROURACIL; FOSCARNET; GABAPENTIN; GANCICLOVIR; IMMUNOGLOBULIN M; OPIATE; PARACETAMOL; SORIVUDINE; VALACICLOVIR;

ACUTE DISEASE; AGE; ARTICLE; BIOAVAILABILITY; BONE MARROW SUPPRESSION; CARCINOGENIC ACTIVITY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DOSE RESPONSE; DRUG EFFICACY; EYE INFECTION; FLUORESCENCE; HERPES ZOSTER; HUMAN; IMMUNE DEFICIENCY; LABORATORY DIAGNOSIS; LABORATORY TEST; MEDICAL SOCIETY; NONHUMAN; PATIENT REFERRAL; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RISK FACTOR; SIDE EFFECT; TREATMENT INDICATION; VARICELLA ZOSTER VIRUS; VIRUS LOAD; VIRUS REACTIVATION; VIRUS TITRATION;

EID: 0037375068     PISSN: 13866532     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1386-6532(03)00032-5     Document Type: Article

References (17)

1. Beards G., Graham C., Pillay D. Investigation of vesicular rashes for HSV and VZV by PCR. J. Med. Virol. 54:(3):1998;155-157.
2. Breuer J. Varicella zoster virus. In: Banatvala J, Zuckerman A, Pattison J, editors. Principles and practice of clinical virology. Cambridge University Press; 2003 (in press).
3. Breuer J., et al. Guidelines for the management of shingles. Report of a Working Group of the British Society for the Study of Infection (BSSI). J. Infection. 30:1995;193-200.
4. Brisson M., Gay N.J., Edmunds W.J., Andrews N.J. Exposure to varicella boosts immunity to herpes-zoster: implications for mass vaccination against chickenpox. Vaccine. 20:(19-20):2002;2500-2507.
5. de Jong M.D., Weel J.F., van Oers M.H., et al. Molecular diagnosis of visceral herpes zoster. Lancet. 357:(9274):2001;2101-2102.
6. Diasio R.B. Sorivudine and 5-fluorouracil: a clinically significant drug-drug interaction due to inhibition of dihydropyrimidine dehydrogenase. Br. J. Clin. Pharmacol. 46:(1):1998;1-4.
7. Engstrom R.E. Jr., Holland G.N., Margolis T.P., et al. The progressive outer retinal necrosis syndrome. A variant of necrotizing herpetic retinopathy in patients with AIDS. Ophthalmology. 101:(9):1994;1488-1502.
8. Fahrig R. Anti-recombinogenic and convertible co-mutagenic effects of (E)-5-(2-bromovinyl)-2′-deoxyuridine (BVDU) and other 5-substituted pyrimidine nucleoside analogs in S. cerevisiae MP1. Mutat Res. 372:(1):1996;133-139.
9. Johnson R. Herpes zoster - predicting and minimizing the impact of post-herpetic neuralgia. J. Antimicrob. Chemother. 47:(Suppl T1):2001;1-8.
10. Johnson R, Patrick D, editors. Improving the management of varicella, herpes zoster and zoster associated pain. International Herpes Management Forum (IHMF) 2002.
11. Koshiniemi M., Rantalaiho T., Piiparinen H., et al. Infections of the central nervous system of suspected viral origin: a collaborative study from Finland. J. Neurovirol. 7:(5):2001;400-408.
12. Moorthy R.S., Weinberg D.V., Teich S.A., et al. Management of varicella zoster virus retinitis in AIDS. Br. J. Ophthalmol. 81:(3):1997;189-194.
13. Oladepo D.K., Klapper P.E., Percival D., Vallely P.J. Serological diagnosis of varicella-zoster virus in sera with antibody-capture enzyme-linked immunosorbent assay of IgM. J. Virol. Methods. 84:(2):2000;169-173.
14. Ormerod L.D., Larkin J.A., Margo C.A., et al. Rapidly progressive herpetic retinal necrosis: a blinding disease characteristic of advanced AIDS. Clin. Infect. Dis. 26:(1):1998;34-45. discussion 46-7.
15. Perez-Blazquez E., Traspas R., Mendez Marin I., Montero M. Intravitreal ganciclovir treatment in progressive outer retinal necrosis. Am. J. Ophthalmol. 124:(3):1997;418-421.
16. Schliefer K., Gumbel H.O., Rockstroh J.K., Spengler U. Management of progressive outer retinal necrosis with cidofovir in a human immunodeficiency virus-infected patient. Clin. Infect. Dis. 29:(3):1999;684-685.
17. Sundqvist V. Frequency and specificity of varicella zoster IgM response. J. Virol. Methods. 5:1982;219-227.